MedTrace Logo

Fastigial Nucleus Stimulation for Coronary Heart Disease

NCT04121715 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2019-10-10

No results posted yet for this study

Summary

To observe the effects of fastigial nucleus stimulation on serum inflammation, oxidative stress related factors, cardiac autonomic function and prognosis in patients with coronary heart disease

Conditions

  • Coronary Disease

Interventions

DEVICE

Fastigial Nucleus Stimulation

Select mode 3, frequency 136, intensity below 90, ratio 1.0-2.0, based on the patient's no discomfort. The main pole is attached to the bilateral mastoid, and the auxiliary pole is attached to the bilateral internal cave. Non-invasive introduction of bio-electricity into the cerebellar nucleus for stimulation

DRUG

Standard treatment

Refer to the "Guidelines for Rational Use of Coronary Heart Diseases".rational selection of antiplatelet drugs, statins, etc. according to the patient's condition

Sponsors & Collaborators

  • the Third Hospital of Mianyang

    collaborator UNKNOWN

  • Affiliated Hospital of North Sichuan Medical College

    lead OTHER

Principal Investigators

  • Runfeng Zhang, Ph.D · the Third Hospital of Mianyang

  • Wensong Li, master · the Third Hospital of Mianyang

  • Xin Lei, master · Affiliated Hospital of North Sichuan Medical College

  • Xiaoju Liu, master · Affiliated Hospital of North Sichuan Medical College

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-16
Primary Completion
2021-01-31
Completion
2022-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04121715 on ClinicalTrials.gov